Navigation Links
Cardiac patients given longer prescriptions at discharge more likely to continue taking medication
Date:6/28/2013

Elderly cardiac patients prescribed heart medications for 60 days or more after leaving hospital have four times the odds of adhering to the drug regime than patients prescribed the same medications for 30 days, according to research conducted at the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital (WCH).

The study, published today in the Canadian Journal of Cardiology, found longer initial prescriptions when leaving hospital are associated with long-term adherence in elderly patients. The findings suggest prescriptions covering a longer interval of time are both more patient-centered and more effective.

"Studies show that adherence to cardiac medications after a cardiac event like a heart attack declines over time. But we know that taking these medications for the long-term is absolutely essential for preventing further cardiac events," said Dr. Noah Ivers, lead author of the study and family physician at Women's College Hospital. "This study shows that longer prescriptions for cardiac patients after leaving hospital increase the likelihood that patients will take the medications for the long term, which may reduce their risk of heart attacks, stroke or even death."

In the study, researchers investigated medication adherence of more than 20,000 elderly patients with coronary artery disease to three common classes of cardiac medications ACE inhibitors, beta blockers and statins. For an 18-month period, the researchers compared the results of those prescribed the medications for less than 30 days, for 30-60 days and for 60 days or more. They found:

  • Patients prescribed the medication for 60 days or more were more likely to adhere to the medication in the long term than those prescribed the medication for 30 days or less
  • Older patients were less likely to adhere to medications.
  • Male patients were more likely to continue to take some medications but not others.
  • Up to 50 per cent of prescriptions covered only 7 days.
  • More than 80 per cent of patients had a follow-up appointment within one month, regardless of prescription length.

"The majority of patients in our study left hospital with a prescription for cardiac medications for 30 days or less," said Dr. Ivers. "This may be a result of the common clinical perception that short prescriptions encourage patients to go to their followup appointments, yet our study found regardless of the duration of the prescription, nearly all patients did, in fact, attend their followup appointment."

Short prescriptions may inadvertently suggest to patients and family physicians alike that long-term adherence isn't necessary, the authors suggest.

"When we reduce the requirement for early refills, patients still follow up with their family physician or cardiologist and they are more likely to remain on the medications as well, Dr. Ivers said. "We certainly want to encourage early outpatient follow up after hospitalization, but holding medications ransom may not be the best way to do it."

Modifying the length of a prescription is an easy fix, Dr. Ivers adds.

"Forcing elderly patients to frequently visit their cardiologist or family physician to renew prescriptions is only exacerbating the problem," he said. "While dosage adjustments are sometimes required, increasing the duration of a prescription for cardiac patients can easily be done, leading to significant benefits for patients."


'/>"/>

Contact: Julie Saccone
julie.saccone@wchospital.ca
416-323-6400 x4054
Women's College Hospital
Source:Eurekalert

Related medicine news :

1. SMART heart eases heart ache, targets cardiac patients emotional well-being
2. Erectile dysfunction drug may benefit cardiac function in young patients with heart defects
3. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
4. People With HIV at Higher Odds of Sudden Cardiac Death
5. Study: Heart damage after chemo linked to stress in cardiac cells
6. Study Spots Early Warning Signal for Sudden Cardiac Death
7. Wake Forest Baptist study suggests Tasers dont cause cardiac complications
8. Are cardiac risk factors linked to less blood flow to the brain?
9. Fine tuning cardiac ablation could lead to quicker results for patients with arrhythmias
10. Coordinated Care Boosts Cardiac Arrest Survival: Study
11. Implementing a therapeutic hypothermia program for post-cardiac arrest in acute care hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... MA (PRWEB) , ... June 27, 2017 , ... The ... Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care Act ... compared with what would be expected under current law. , More than 20 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology: